Novo Nordisk is a global pharmaceutical company with a 90-year history of innovation and leadership in the treatment of diabetes. Every day Novo Nordisk diabetes drugs are used by more than 28 million patients * in 180 countries, and this is every second patient in the world. The company also holds leading positions in such areas as hemostasis management, hormone growth therapy, hormone replacement therapy for women and obesity.
The headquarters of Novo Nordisk is located in Denmark. More than 41,000 employees work in 77 branches around the world, and its products are supplied to 165 countries.
Showing all 5 results